Literature DB >> 8784740

Effects of beta-lactam antibiotics on intestinal microflora and bile acid metabolism in rats.

S Hashimoto1, H Igimi, K Uchida, T Satoh, Y Benno, N Takeuchi.   

Abstract

Wistar male rats were treated for six days with broad spectrum beta-lactam antibiotics, latamoxef, and cefotaxime. On the seventh day, the number of fecal anaerobic microbes decreased, total fecal bile acids decreased, and bile acid pools increased. Secondary bile acids such as beta-hyocholic, hyodeoxycholic, lithocholic, and deoxycholic acids decreased in the feces while the primary bile acids, cholic, beta-muricholic, and chenodeoxycholic acids, became predominant. Coprostanol, a microbial metabolite of cholesterol, also disappeared from the feces during the treatment. The cecum enlarged to almost twice the size of that in control rats, whereas the liver weight was not significantly changed. After treatment was stopped, the number of fecal microbes returned to the initial counts within a week, but restoration of bile acid and cholesterol metabolism required at least three weeks.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784740     DOI: 10.1007/bf02523830

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  31 in total

1.  Bile acids. I. Two new acids from rat bile.

Authors:  J T MATSCHINER; T A MAHOWALD; W H ELLIOTT; E A DOISY; S L HSIA; E A DOISY
Journal:  J Biol Chem       Date:  1957-04       Impact factor: 5.157

2.  Effect of aging and dietary restriction on bile acid metabolism in rats.

Authors:  G Ferland; B Tuchweber; A Perea; I M Yousef
Journal:  Lipids       Date:  1989-10       Impact factor: 1.880

3.  Microbial transformation of cholesterol into coprostanol. Properties of a 3-oxo- 4-steroid-5 beta-reductase.

Authors:  I Björkhem; J A Gustafsson; O Wrange
Journal:  Eur J Biochem       Date:  1973-08-01

4.  A simple method ("plate-in-bottle method") for the cultivation of fastidious anaerobes.

Authors:  T Mitsuoka; Y Morishita; A Terada; S Yamamoto
Journal:  Jpn J Microbiol       Date:  1969-12

5.  [Metabolism of bile acids. III. Metabolism of chenodeoxycholic acid (author's transl)].

Authors:  M Ota; H Tsunoda; T Hoshita
Journal:  Yakugaku Zasshi       Date:  1978-01       Impact factor: 0.302

6.  The enzymatic cleavage of the carbon-nitrogen bond in 3-alpha, 7-alpha, 12-alpha-trihydroxy-5-beta-cholan-24-oylglycine.

Authors:  P P Nair; M Gordon; J Reback
Journal:  J Biol Chem       Date:  1967-01-10       Impact factor: 5.157

7.  Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis.

Authors:  E J Stellwag; P B Hylemon
Journal:  Biochim Biophys Acta       Date:  1976-11-08

Review 8.  Intestinal cholesterol metabolism.

Authors:  A H Lichtenstein
Journal:  Ann Med       Date:  1990-02       Impact factor: 4.709

9.  Delta 22-beta-muricholic acid in monoassociated rats and conventional rats.

Authors:  T Kayahara; T Tamura; Y Amuro; K Higashino; H Igimi; K Uchida
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

10.  Age-related changes of bile acid metabolism in rats.

Authors:  K Uchida; T Chikai; H Takase; Y Nomura; S Seo; H Nakao; N Takeuchi
Journal:  Arch Gerontol Geriatr       Date:  1990 Jan-Feb       Impact factor: 3.250

View more
  9 in total

1.  Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies.

Authors:  Dominique Debray; Dominique Rainteau; Véronique Barbu; Myriam Rouahi; Haquima El Mourabit; Stéphanie Lerondel; Colette Rey; Lydie Humbert; Dominique Wendum; Charles-Henry Cottart; Paul Dawson; Nicolas Chignard; Chantal Housset
Journal:  Gastroenterology       Date:  2012-02-24       Impact factor: 22.682

Review 2.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

3.  Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles.

Authors:  J R Allegretti; S Kearney; N Li; E Bogart; K Bullock; G K Gerber; L Bry; C B Clish; E Alm; J R Korzenik
Journal:  Aliment Pharmacol Ther       Date:  2016-04-18       Impact factor: 8.171

Review 4.  Impact of Primary and Secondary Bile Acids on Clostridioides difficile Infection.

Authors:  Agata Łukawska; Agata Mulak
Journal:  Pol J Microbiol       Date:  2022-03-14

5.  Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.

Authors:  Alexa R Weingarden; Chi Chen; Aleh Bobr; Dan Yao; Yuwei Lu; Valerie M Nelson; Michael J Sadowsky; Alexander Khoruts
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-11-27       Impact factor: 4.052

6.  Transmissible microbial and metabolomic remodeling by soluble dietary fiber improves metabolic homeostasis.

Authors:  Baokun He; Kazunari Nohara; Nadim J Ajami; Ryan D Michalek; Xiangjun Tian; Matthew Wong; Susan H Losee-Olson; Joseph F Petrosino; Seung-Hee Yoo; Kazuhiro Shimomura; Zheng Chen
Journal:  Sci Rep       Date:  2015-06-04       Impact factor: 4.379

7.  Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor.

Authors:  Thijs W H Pols; Teresa Puchner; H Inci Korkmaz; Mariska Vos; Maarten R Soeters; Carlie J M de Vries
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

8.  BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection.

Authors:  Philipp Solbach; Patrick Chhatwal; Sabrina Woltemate; Evelina Tacconelli; Michael Buhl; Markus Gerhard; Christoph K Thoeringer; Maria J G T Vehreschild; Nathalie Jazmati; Jan Rupp; Michael P Manns; Oliver Bachmann; Sebastian Suerbaum
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.240

9.  Metabolism of bile salts in mice influences spore germination in Clostridium difficile.

Authors:  Jennifer L Giel; Joseph A Sorg; Abraham L Sonenshein; Jun Zhu
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.